The Lancet Diabetes & Endocrinology
is dedicated to providing a global, authoritative, and independent forum for high impact
clinical research and opinion covering all aspects of endocrinology, diabetes, metabolism, obesity, osteoporosis, bone metabolism, as
well as thyroid, lipid, and adrenal disorders. Continuing in The Lancet
's tradition of publishing high-impact content that influences
medical practice, the journal delivers essential research, expert review, and candid commentary to provide context and perspective on
important advances shaping these fields today.
The Lancet Diabetes & Endocrinology is stringently edited and peer-reviewed
to ensure the scientific merit and clinical relevance of its diverse content. Original Research is fast-tracked to publication within
8 weeks on average of submission and published Online First on http://www.thelancet.comwww.thelancet.com
before appearing in print.
Now indexed in PubMed, Journal Citation Reports®, and Scopus, the journal accepts submissions of Original
Research, Review, and Personal Views. Visit http://ees.elsevier.com/thelancetde to learn more about our editorial scope
and aims and to submit your manuscript.
Gold or Green Open Access is available for research supported by selected funding agencies
with whom Elsevier has an agreement. The journal is also freely available to readers in low-to-middle-income countries via the HINARI
programme or via IP access at http://www.thelancet.comwww.thelancet.com.
To find out more about
The Lancet Diabetes & Endocrinology, visit http://www.thelancet.com/diabetes-endocrinologywww.thelancet.com/diabetes-endocrinology.